| scholarly article | Q13442814 |
| P2093 | author name string | Neve KA | |
| Eshleman AJ | |||
| Janowsky A | |||
| Henningsen RA | |||
| P433 | issue | 2 | |
| P304 | page(s) | 312-316 | |
| P577 | publication date | 1994-02-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Release of dopamine via the human transporter | |
| P478 | volume | 45 |
| Q24642179 | A receptor mechanism for methamphetamine action in dopamine transporter regulation in brain |
| Q34376469 | A regenerative approach to the treatment of multiple sclerosis |
| Q36823398 | Adolescent binge-like alcohol alters sensitivity to acute alcohol effects on dopamine release in the nucleus accumbens of adult rats |
| Q34891738 | Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo. |
| Q38919961 | Autophagy inhibition by caffeine increases toxicity of methamphetamine in SH-SY5Y neuroblastoma cell line |
| Q28067373 | Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose |
| Q34756340 | Bupropion, methylphenidate, and 3,4-methylenedioxypyrovalerone antagonize methamphetamine-induced efflux of dopamine according to their potencies as dopamine uptake inhibitors: implications for the treatment of methamphetamine dependence. |
| Q41078201 | Characterization of glycine release mediated by glycine transporter 1 stably expressed in HEK-293 cells |
| Q36052518 | Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission |
| Q33960234 | Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study |
| Q73952054 | Dopaminergic characteristics of isolated parietal cells from rats |
| Q34272184 | Estrogens of multiple classes and their role in mental health disease mechanisms |
| Q43820036 | Ethanol potentiates the function of the human dopamine transporter expressed inXenopusoocytes |
| Q28731615 | Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: selecting appropriate phenotypes for reward dependence behaviors |
| Q30413183 | Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior |
| Q26781554 | Insights to ligand binding to the monoamine transporters-from homology modeling to LeuBAT and dDAT |
| Q34070426 | Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing |
| Q44598014 | Involvement of non-exocytotic mechanisms in ethanol-induced in vivo dopamine release: comparisons with cocaine |
| Q28264438 | Lobeline effects on tonic and methamphetamine-induced dopamine release |
| Q28263277 | Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter |
| Q27334784 | Membrane potential shapes regulation of dopamine transporter trafficking at the plasma membrane |
| Q46252209 | Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway. |
| Q57726158 | Methamphetamine-induced locomotor activity and sensitization in dopamine transporter and vesicular monoamine transporter 2 double mutant mice |
| Q24800348 | N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux |
| Q36849881 | Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART). |
| Q58580546 | Neuropharmacology of Synthetic Cathinones |
| Q36856162 | Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDS |
| Q27316816 | Neurotransmitter and psychostimulant recognition by the dopamine transporter |
| Q36205828 | New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylate |
| Q35044809 | Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP+) but not release of MPP+ in rat C6 glioma cells expressing human dopamine transporter |
| Q38609231 | Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis |
| Q34517414 | Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677. |
| Q50138266 | Phosphorylation of the Amino Terminus of the Dopamine Transporter: Regulatory Mechanisms and Implications for Amphetamine Action. |
| Q37156621 | Proline-directed phosphorylation of the dopamine transporter N-terminal domain |
| Q37406074 | Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons |
| Q34602596 | Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. |
| Q34172920 | Sex Differences in Striatal Dopamine Release in Young Adults After Oral Alcohol Challenge: A Positron Emission Tomography Imaging Study With [11C]Raclopride |
| Q36275183 | The SLC6A3 gene possibly affects susceptibility to late-onset alcohol dependence but not specific personality traits in a Han Chinese population |
| Q52649972 | The dopamine transporter: An unrecognized nexus for dysfunctional peripheral immunity and signaling in Parkinson's Disease |
| Q48132395 | The effect of aging on dopamine release and metabolism during sevoflurane anesthesia in rat striatum: An in vivo microdialysis study |
| Q22242368 | The emerging role of trace amine-associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity |
| Q37627941 | The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango. |
| Q34541196 | Time-of-day differences in dopamine clearance in the rat medial prefrontal cortex and nucleus accumbens. |
| Q42552999 | Translocation of dopamine and binding of WIN 35,428 measured under identical conditions in cells expressing the cloned human dopamine transporter |
Search more.